Last reviewed · How we verify

Anesthetic Adjuncts

Beth Israel Deaconess Medical Center · FDA-approved active Small molecule

Anesthetic adjuncts are medications used alongside primary anesthetics to enhance anesthesia quality, reduce pain, and improve patient outcomes during surgical procedures.

Anesthetic adjuncts are medications used alongside primary anesthetics to enhance anesthesia quality, reduce pain, and improve patient outcomes during surgical procedures. Used for Adjunctive use in general anesthesia, Perioperative anxiolysis and analgesia, Sedation during surgical procedures.

At a glance

Generic nameAnesthetic Adjuncts
Also known asopioids, propofol, dexmedetomidine or ketamine
SponsorBeth Israel Deaconess Medical Center
Drug classAnesthetic adjunct (mixed class)
ModalitySmall molecule
Therapeutic areaAnesthesiology
PhaseFDA-approved

Mechanism of action

Anesthetic adjuncts work through various mechanisms depending on the specific agent—commonly including anxiolysis, analgesia, sedation, or muscle relaxation. They are administered in combination with primary anesthetics (such as propofol or volatile agents) to optimize anesthetic depth, reduce required doses of primary agents, and manage perioperative pain and anxiety. Common adjuncts include opioids, benzodiazepines, alpha-2 agonists, and neuromuscular blocking agents.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: